Citadel Advisors
DRIO icon

Citadel Advisors’s DarioHealth DRIO Stock Holding History

Citadel Advisors’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$164K Buy
+20,460
New +$214K ﹤0.01% 11607
2025
Q1 		– Sell
-3,597
Closed -$50.8K – 14677
2024
Q4 		$56.5K Buy
3,597
+279
+8% +$4.83K ﹤0.01% 12254
2024
Q3 		$74.3K Buy
3,318
+480
+17% +$9.73K ﹤0.01% 11486
2024
Q2 		$67.5K Buy
+2,838
New +$80.4K ﹤0.01% 11415
2024
Q1 		– Sell
-1,971
Closed -$74.7K – 14711
2023
Q4 		$67.8K Buy
1,971
+719
+57% +$25.6K ﹤0.01% 11422
2023
Q3 		$82.1K Sell
1,252
-1,908
-60% -$129K ﹤0.01% 11143
2023
Q2 		$253K Sell
3,160
-1,531
-33% -$116K ﹤0.01% 9382
2023
Q1 		$387K Buy
4,691
+4,604
+5,292% +$452K ﹤0.01% 8841
2022
Q4 		$7.45K Sell
87
-1,058
-92% -$95.2K ﹤0.01% 13824
2022
Q3 		$106K Sell
1,145
-6,135
-84% -$659K ﹤0.01% 11036
2022
Q2 		$895K Buy
7,280
+3,349
+85% +$393K ﹤0.01% 7278
2022
Q1 		$459K Buy
3,931
+2,765
+237% +$457K ﹤0.01% 9594
2021
Q4 		$303K Sell
1,166
-424
-27% -$129K ﹤0.01% 10896
2021
Q3 		$434K Buy
1,590
+997
+168% +$288K ﹤0.01% 10227
2021
Q2 		$253K Sell
593
-247
-29% -$94K ﹤0.01% 11668
2021
Q1 		$324K Buy
+840
New +$378K ﹤0.01% 10668
2019
Q4 		– Sell
-132
Closed -$16K – 9229
2019
Q3 		$16K Buy
132
+100
+313% +$17.3K ﹤0.01% 8984
2019
Q2 		$6K Sell
32
-74
-70% -$19.2K ﹤0.01% 9067
2019
Q1 		$31K Buy
+106
New +$31.5K ﹤0.01% 8983
2018
Q4 		– Sell
-45
Closed -$17K – 9233
2018
Q3 		$17K Sell
45
-2
-4% -$918 ﹤0.01% 9037
2018
Q2 		$24K Buy
+47
New +$30.7K ﹤0.01% 8604

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citadel Advisors's DRIO Position: Q1 2026 in Review

Citadel Advisors opened a new position in DarioHealth (DRIO) in Q1 2026: 20,460 shares worth $164K. The stake represents ﹤0.01% of the portfolio and ranks #11607 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in DRIO as recently as Q4 2024.

Citadel Advisors first reported a position in DRIO in Q2 2018 and has held it in 21 quarters since. The position peaked at $895K in Q2 2022. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.

  • Citadel Advisors held 20,460 shares of DarioHealth worth $164K as of Q1 2026.
  • DarioHealth was a new Citadel Advisors position in Q1 2026.
  • DarioHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11607 holding.
  • Citadel Advisors first reported a position in DarioHealth in Q2 2018 and has held it in 21 quarters since.
  • Citadel Advisors's DarioHealth position peaked at $895K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.